Jazz Pharmaceuticals (JAZZ) News Today $138.53 +0.35 (+0.25%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$138.42 -0.12 (-0.08%) As of 10/24/2025 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock JAZZ Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Moloney Securities Asset Management LLC1 hour ago | marketbeat.comCwm LLC Boosts Stake in Jazz Pharmaceuticals PLC $JAZZ4 hours ago | marketbeat.comFirst Citizens Bank & Trust Co. Has $1 Million Stock Position in Jazz Pharmaceuticals PLC $JAZZOctober 25 at 5:58 AM | marketbeat.comAvadel Settles With Jazz Pharmaceuticals, Gets Acquired By AlkermesOctober 23 at 12:50 PM | seekingalpha.comVanguard Personalized Indexing Management LLC Decreases Stake in Jazz Pharmaceuticals PLC $JAZZOctober 23 at 3:46 AM | marketbeat.comWells Fargo says Avadel settlemnet adds $5 to Jazz Pharmaceuticals DCFOctober 22, 2025 | msn.comAvadel, Jazz Pharmaceuticals End Patent Dispute With SettlementOctober 22, 2025 | marketwatch.comJazz Pharmaceuticals to Report Third Quarter Financial Results on November 5, 2025October 22, 2025 | prnewswire.com23,900 Shares in Jazz Pharmaceuticals PLC $JAZZ Bought by VIRGINIA RETIREMENT SYSTEMS ET AlOctober 22, 2025 | marketbeat.comIambic Announces Research Collaboration with Jazz Pharmaceuticals for IAM1363 and Zanidatamab Combination Cohort in HER2-Positive Breast CancerOctober 21, 2025 | finance.yahoo.comJohn G Ullman & Associates Inc. Sells 3,208 Shares of Jazz Pharmaceuticals PLC $JAZZOctober 19, 2025 | marketbeat.comJazz Pharmaceuticals PLC $JAZZ Shares Purchased by Allianz Asset Management GmbHOctober 19, 2025 | marketbeat.comEnvestnet Portfolio Solutions Inc. Purchases 7,465 Shares of Jazz Pharmaceuticals PLC $JAZZOctober 19, 2025 | marketbeat.comPraxis Precision’s tremor-drug trial succeeds where others have failed. The stock is skyrocketing.October 16, 2025 | msn.comJazz Pharmaceuticals PLC $JAZZ Holdings Lifted by Bayforest Capital LtdOctober 15, 2025 | marketbeat.comBoston Trust Walden Corp Buys 229,885 Shares of Jazz Pharmaceuticals PLC $JAZZOctober 15, 2025 | marketbeat.comCallan Family Office LLC Buys New Position in Jazz Pharmaceuticals PLC $JAZZOctober 14, 2025 | marketbeat.comAssessing Jazz Pharmaceuticals (JAZZ) Valuation Following Strong Recent Share Price MomentumOctober 13, 2025 | finance.yahoo.comQ3 EPS Forecast for Jazz Pharmaceuticals Reduced by AnalystOctober 13, 2025 | marketbeat.comJazz Pharmaceuticals PLC $JAZZ Shares Sold by Meritage Portfolio ManagementOctober 12, 2025 | marketbeat.comJazz Pharmaceuticals PLC $JAZZ Shares Purchased by KLP Kapitalforvaltning ASOctober 12, 2025 | marketbeat.comZacks Research Has Positive Forecast for JAZZ Q2 EarningsOctober 11, 2025 | marketbeat.comLmcg Investments LLC Lowers Stake in Jazz Pharmaceuticals PLC $JAZZOctober 11, 2025 | marketbeat.comRBC Capital Sticks to Their Buy Rating for Jazz Pharmaceuticals (JAZZ)October 11, 2025 | theglobeandmail.comZymeworks initiated with a Buy at B. RileyOctober 10, 2025 | msn.comLeerink Partnrs Has Bearish Estimate for JAZZ Q3 EarningsOctober 10, 2025 | marketbeat.comTruist Financial Remains a Buy on Jazz Pharmaceuticals (JAZZ)October 9, 2025 | theglobeandmail.comWeiss Ratings Reiterates "Sell (D)" Rating for Jazz Pharmaceuticals (NASDAQ:JAZZ)October 9, 2025 | marketbeat.comDeutsche Bank Sticks to Its Buy Rating for Jazz Pharmaceuticals (JAZZ)October 5, 2025 | theglobeandmail.comDeutsche Bank Sticks to Its Buy Rating for Jazz Pharmaceuticals (JAZZ)October 5, 2025 | theglobeandmail.comRobeco Institutional Asset Management B.V. Sells 92,794 Shares of Jazz Pharmaceuticals PLC $JAZZOctober 5, 2025 | marketbeat.comJazz Pharmaceuticals PLC (NASDAQ:JAZZ) Receives Consensus Recommendation of "Moderate Buy" from AnalystsOctober 5, 2025 | marketbeat.comJazz Pharmaceuticals (NASDAQ:JAZZ) Director Sells $263,560.00 in StockOctober 4, 2025 | insidertrades.comPolaris Capital Management LLC Decreases Stake in Jazz Pharmaceuticals PLC $JAZZOctober 4, 2025 | marketbeat.comInsider Selling: Jazz Pharmaceuticals (NASDAQ:JAZZ) Director Sells 2,000 Shares of StockOctober 3, 2025 | marketbeat.comJazz Pharmaceuticals (NASDAQ:JAZZ) Director Bruce Cozadd Sells 3,500 SharesOctober 3, 2025 | marketbeat.comJazz Pharma's combination therapy for lung cancer gets US approvalOctober 3, 2025 | msn.comJazz Pharmaceuticals announces FDA approves Zepzelca in ES-SCLCOctober 3, 2025 | msn.comFDA Approves Genentech’s Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung CancerOctober 2, 2025 | finance.yahoo.comJazz Pharma, Roche's combination therapy for lung cancer gets US approvalOctober 2, 2025 | msn.comFDA Approves Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung CancerOctober 2, 2025 | prnewswire.comUS FDA approves Jazz Pharma's combination therapy for lung cancerOctober 2, 2025 | yahoo.comUS FDA approves Jazz Pharma's therapy for lung cancerOctober 2, 2025 | reuters.comJazz Pharmaceuticals (JAZZ) Gets Price Target Boost Following Positive Xywav Phase 4 DataOctober 2, 2025 | finance.yahoo.comJazz Pharmaceuticals PLC $JAZZ Shares Acquired by Philip James Wealth Mangement LLCOctober 2, 2025 | marketbeat.comPark Avenue Securities LLC Takes Position in Jazz Pharmaceuticals PLC $JAZZOctober 1, 2025 | marketbeat.comStocks Generating Improved Relative Strength: Jazz PharmaceuticalsSeptember 30, 2025 | msn.comState of Alaska Department of Revenue Boosts Stake in Jazz Pharmaceuticals PLC $JAZZSeptember 29, 2025 | marketbeat.comExploring the Valuation of Jazz Pharmaceuticals (JAZZ) Following Recent Share Price MovesSeptember 27, 2025 | finance.yahoo.comPiper Sandler Reaffirms Jazz Pharmaceuticals (JAZZ) Price Target Ahead of Trial DataSeptember 27, 2025 | msn.com Get Jazz Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for JAZZ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. JAZZ Media Mentions By Week JAZZ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JAZZ News Sentiment▼0.750.84▲Average Medical News Sentiment JAZZ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JAZZ Articles This Week▼1414▲JAZZ Articles Average Week Get the Latest News and Ratings for JAZZ and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Jazz Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AXSM News RPRX News CORT News PRGO News SUPN News NKTR News PCRX News OMER News ASMB News CPIX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:JAZZ) was last updated on 10/26/2025 by MarketBeat.com Staff From Our PartnersU.S. Government Sparking Crypto RallyMissed Bitcoin when it was $100? You’re not alone. Crypto runs in cycles—and the next one is already underw...Crypto 101 Media | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredBuy the dip? Here’s my #1 gold stock“The most obvious opportunity in gold stocks I’ve seen in my career” While everyone is distracted by gold’s...Golden Portfolio | SponsoredThe strategy that wins no matter where the market goesJoel and Adam have built a crypto trading system with a 93% win rate — even through volatile, sideways markets...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?While headlines point to collapsing sales and fading tax credits, tech analyst Jeff Brown says Tesla is on the...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jazz Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Jazz Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
